1. Home
  2. LTRY vs MYNZ Comparison

LTRY vs MYNZ Comparison

Compare LTRY & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRY
  • MYNZ
  • Stock Information
  • Founded
  • LTRY 2015
  • MYNZ 2021
  • Country
  • LTRY United States
  • MYNZ Germany
  • Employees
  • LTRY N/A
  • MYNZ N/A
  • Industry
  • LTRY Computer Software: Prepackaged Software
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRY Technology
  • MYNZ Health Care
  • Exchange
  • LTRY Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • LTRY 8.8M
  • MYNZ 9.8M
  • IPO Year
  • LTRY N/A
  • MYNZ 2021
  • Fundamental
  • Price
  • LTRY $1.31
  • MYNZ $0.48
  • Analyst Decision
  • LTRY
  • MYNZ Buy
  • Analyst Count
  • LTRY 0
  • MYNZ 2
  • Target Price
  • LTRY N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • LTRY 193.1K
  • MYNZ 1.3M
  • Earning Date
  • LTRY 08-20-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • LTRY N/A
  • MYNZ N/A
  • EPS Growth
  • LTRY N/A
  • MYNZ N/A
  • EPS
  • LTRY N/A
  • MYNZ N/A
  • Revenue
  • LTRY $6,626,564.00
  • MYNZ $895,479.00
  • Revenue This Year
  • LTRY N/A
  • MYNZ $67.40
  • Revenue Next Year
  • LTRY N/A
  • MYNZ $191.13
  • P/E Ratio
  • LTRY N/A
  • MYNZ N/A
  • Revenue Growth
  • LTRY 75.84
  • MYNZ 69.00
  • 52 Week Low
  • LTRY $0.82
  • MYNZ $0.32
  • 52 Week High
  • LTRY $13.00
  • MYNZ $4.90
  • Technical
  • Relative Strength Index (RSI)
  • LTRY 54.88
  • MYNZ 47.27
  • Support Level
  • LTRY $0.92
  • MYNZ $0.39
  • Resistance Level
  • LTRY $1.68
  • MYNZ $0.56
  • Average True Range (ATR)
  • LTRY 0.15
  • MYNZ 0.09
  • MACD
  • LTRY 0.04
  • MYNZ 0.02
  • Stochastic Oscillator
  • LTRY 51.97
  • MYNZ 66.45

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: